Abstract
Wound Healing Events and Effusions with Everolimus Versus MMF Based Regimens in De Novo Heart Transplant Recipients A. Zuckermann, H. Eisen, J. Kobashigawa, H. Ross, S. Wang, H. Lehmkuhl, M. Rinaldi, G. Torre, N. Yonan, J. Arizon, C. Pellegrini, P. Lopez, G. Dong, C. Panis, S. Hirt. Medical University Vienna, Vienna, Austria; Division of Cardiology, Drexel University College of Medicine, Philadelphia; Heart Transplant Program, Cedars-Sinai Heart Institute, Los Angeles, CA; Department of Cardiology/Heart Transplant, University Health Network, Toronto General Hospital, Toronto, Canada; Division of Cardiovascular Surgery, National Taiwan University, Taipei, Taiwan; Deutsches Herzzentrum Berlin, Berlin, Germany; S. Giovanni Battista Hospital, University of Turin, Torino, Italy; Methodist Hospital/DeBakey Heart Failure Research Center, Houston; Wythenshawe Hospital, Manchester, United Kingdom; Department of Cardiology, Reina Sofia University Hospital, Cordoba, Spain; Az. Osp.di Bologna Policl.S.OrsolaMalpighi Univ.degli Studi, Bologna, Italy; Novartis Pharma AG, Basel, Switzerland; Novartis Pharmaceuticals Corporation, East Hanover; Universitaetsklinikum Regensburg, Regensburg, Germany.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
